A phase 1 multicenter open-label dose-escalation study of BMS-936561 (MDX-1203) in clear cell renal cell carcinoma (ceRCC) and B-cell non Hodgkin lymphoma (B-NHL) Meeting Abstract
| Authors: | Owonikoko, T. K.; Hussain, A.; Stadler, W. M.; Smith, D. C.; Sznol, M.; Molina, A. M.; Gulati, P.; Shah, A.; Ahlers, C. M.; Cardarelli, J.; Cohen, L. J. |
| Abstract Title: | A phase 1 multicenter open-label dose-escalation study of BMS-936561 (MDX-1203) in clear cell renal cell carcinoma (ceRCC) and B-cell non Hodgkin lymphoma (B-NHL) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202823 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.2558 |
| Notes: | Meeting Abstract: 2558 -- Source: Wos |
